Shareholding for the Period Ended June 30, 2017
Caplin Point Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click here10-07-2017
10-07-2017
Caplin Point Labs zooms over 40% in six days on strong Q4 results
The stock hit a new high of Rs 5784, rallied 41% in past six trading sessions from Rs 406 on May 1018-05-2017
Caplin Point Lab surges 15% on strong Q4 results
The stock hit a 52-week high of Rs 467 after the company posted 114% growth in profit at Rs 33 cr11-05-2017
Press Release
Press Release with respect to the Financial results for the quarter/year ended March 31,201710-05-2017
AUDITED FINANCIAL RESULTS FOR THE QUARTER /YEAR ENDED MARCH 31,2017
AUDITED FINANCIAL RESULTS FOR THE QUARTER /YEAR ENDED MARCH 31,201710-05-2017
Board approves Dividend
The Board of Directors of the Company at their meeting held today, May 10,2017, have recommended a Dividend of 75% (i.e) Rs. 1.50 paise per equity share at the face value of Rs.2 each for the financial year ended March 31,201710-05-2017
Caplin Point gets EIR for sterile injectable plant
Caplin Point Laboratories has received the Establishment Inspection Report from the US health regulator for its Gummidopoondi facility in Chennai. Caplin Point has received the Establishment...08-05-2017
Board Meeting On May 10,2017
The meeting of the Board of Directors of the Company is scheduled to be held on WEDNESDAY, MAY 10,2017 inter alia: 1.To consider and approve the Audited Financial Results for the quarter/year ended March 31,2017. 2.Recommendation of Dividend for the financial year 2016-17 Accordingly, the Trading Window for dealing in the equity shares of the Company will remain closed for Promoters, Directors, other Connected Persons and...17-04-2017